$3.12B
Revenue
$277.50M
Net Income
43.92%
Gross Margin
10.60%
Op. Margin
$621.90M
Free Cash Flow
| Breakdown | TTM (Dec 31, 2020) |
FY 2020 (Sep 30, 2020) |
FY 2019 (Sep 30, 2019) |
FY 2018 (Sep 30, 2018) |
FY 2017 (Sep 30, 2017) |
FY 2016 (Sep 30, 2016) |
|---|---|---|---|---|---|---|
| Total Revenue | $3.12B | $3.17B | $3.23B | $2.92B | $2.62B | $3.22B |
| Revenue Growth % | -1.6% | -1.8% | 10.5% | 11.4% | -18.6% | nan% |
| Cost of Revenue | $1.75B | $1.79B | $1.85B | $1.65B | $1.51B | $1.86B |
| Gross Profit | $1.37B | $1.38B | $1.37B | $1.27B | $1.11B | $1.36B |
| Gross Margin % | 43.9% | 43.5% | 42.5% | 43.6% | 42.5% | 42.3% |
| Operating Expenses | $1.04B | $1.05B | $984.10M | $836.20M | $816.10M | $810.50M |
| Research & Development | $285.70M | $280.60M | $247.60M | $233.90M | $210.00M | $253.50M |
| Selling General & Admin | $656.70M | $671.80M | $623.10M | $543.50M | $552.80M | $540.10M |
| Operating Income | $330.40M | $323.20M | $386.20M | $437.40M | $297.80M | $550.80M |
| Operating Margin % | 10.6% | 10.2% | 12.0% | 15.0% | 11.4% | 17.1% |
| Interest Expense | $10.60M | $14.00M | $8.80M | $6.80M | $10.70M | $11.80M |
| Interest Income | $10.20M | $10.40M | $15.10M | $17.30M | $13.60M | $17.40M |
| Other Income/Expense | - | $38.70M | $28.30M | $4.20M | $2.40M | - |
| Income Before Tax | - | - | $420.80M | $452.10M | $303.10M | $556.40M |
| Income Tax Expense | $92.70M | $88.90M | $128.60M | $301.80M | $77.10M | $153.70M |
| Net Income | $277.50M | $269.20M | $291.90M | $149.90M | $218.50M | $402.30M |
| Net Margin % | 8.9% | 8.5% | 9.1% | 5.1% | 8.3% | 12.5% |
| Basic EPS | 3.05 | 2.96 | 3.21 | 1.64 | 2.36 | 4.22 |
| Diluted EPS | 3.02 | 2.94 | 3.18 | 1.62 | 2.35 | 4.19 |
| Basic Shares Outstanding | 91.4M | 90.9M | 91.0M | 91.5M | 92.5M | 95.4M |
| Diluted Shares Outstanding | 92.2M | 91.5M | 91.9M | 92.5M | 93.2M | 96.0M |
| Breakdown | FY 2020 (Sep 30, 2020) |
FY 2019 (Sep 30, 2019) |
FY 2018 (Sep 30, 2018) |
FY 2017 (Sep 30, 2017) |
FY 2016 (Sep 30, 2016) |
|---|---|---|---|---|---|
| Cash & Cash Equivalents | $766.10M | $531.40M | $504.80M | $716.20M | $843.50M |
| Short-term Investments | - | - | - | - | $95.30M |
| Accounts Receivable | $1.07B | $1.11B | $1.01B | $823.50M | $891.80M |
| Inventory | $516.30M | $551.50M | $438.10M | $439.70M | $639.70M |
| Other Current Assets | $254.80M | $206.20M | $233.30M | $199.80M | $145.70M |
| Total Current Assets | $2.60B | $2.40B | $2.19B | $2.19B | $2.62B |
| Property Plant & Equipment | - | $311.50M | $274.60M | $255.30M | $379.20M |
| Goodwill | $623.90M | $612.20M | $293.60M | $222.60M | $294.70M |
| Intangible Assets | $271.30M | $300.70M | $101.10M | $71.60M | $104.70M |
| Other Non-current Assets | $416.30M | $397.20M | $292.80M | $300.80M | $282.50M |
| Total Assets | $4.46B | $4.10B | $3.25B | $3.18B | $3.82B |
| Accounts Payable | $194.90M | $248.50M | $190.30M | $162.30M | $201.10M |
| Short-term Debt | $355.00M | $410.00M | - | $350.00M | $329.60M |
| Accrued Liabilities | $522.40M | $459.50M | $419.70M | $394.70M | $412.70M |
| Deferred Revenue | $782.20M | $766.00M | $729.70M | $640.60M | $620.60M |
| Total Current Liabilities | $1.85B | $1.88B | $1.34B | $1.55B | $1.61B |
| Long-term Debt | - | - | - | - | $287.50M |
| Other Non-current Liabilities | $421.80M | $440.10M | $324.30M | $130.00M | $160.00M |
| Total Liabilities | $2.38B | $2.32B | $1.66B | $1.68B | $2.06B |
| Common Stock | $91.20M | $90.80M | $91.20M | $91.70M | $93.70M |
| Retained Earnings | $1.13B | $934.00M | $780.40M | $756.00M | $1.07B |
| Total Stockholders Equity | $2.08B | $1.77B | $1.58B | $1.50B | $1.74B |
| Total Liabilities & Equity | $4.46B | $4.10B | $3.25B | $3.18B | $3.82B |
| Breakdown | TTM (Dec 31, 2020) |
FY 2020 (Sep 30, 2020) |
FY 2019 (Sep 30, 2019) |
FY 2018 (Sep 30, 2018) |
FY 2017 (Sep 30, 2017) |
FY 2016 (Sep 30, 2016) |
|---|---|---|---|---|---|---|
| Net Income | $365.70M | $269.20M | $291.90M | $149.90M | $218.50M | $402.30M |
| Stock-based Compensation | $86.80M | $43.90M | $47.90M | $45.90M | $41.20M | $48.30M |
| Deferred Income Tax | $33.10M | $26.90M | $18.90M | $48.00M | $-23.30M | $-23.90M |
| Change in Receivables | $-114.20M | $-35.20M | $111.70M | $76.10M | $18.00M | $168.30M |
| Change in Inventory | $66.40M | $-39.80M | $106.90M | $16.40M | $7.20M | $27.70M |
| Change in Payables | $-113.60M | $-66.90M | $49.70M | $21.90M | $5.50M | $9.70M |
| Operating Cash Flow | $760.00M | $484.10M | $371.80M | $454.90M | $399.10M | $356.30M |
| Capital Expenditure | $138.10M | $84.30M | $58.00M | $47.70M | $59.10M | $80.40M |
| Acquisitions | $45.10M | $36.20M | $576.20M | $109.00M | $3.00M | $21.10M |
| Purchases of Investments | - | - | $32.80M | $10.10M | $8.40M | $600.00K |
| Investing Cash Flow | $-204.10M | $-140.30M | $-631.70M | $-174.70M | $-130.40M | $-109.20M |
| Debt Repayment | - | - | $636.50M | $503.30M | $223.50M | $133.00M |
| Stock Repurchased | $172.40M | $86.20M | $166.70M | $181.90M | $294.50M | $461.30M |
| Financing Cash Flow | $-149.80M | $-93.10M | $279.20M | $-487.00M | $-392.40M | $-245.80M |
| Net Change in Cash | $393.90M | $241.70M | $27.70M | $-202.10M | $-127.60M | $-2.00M |
SEC Filing Format - Data shown as it appears in the Q1 2021 (10-Q) filing
Period ended: Dec 31, 2020
Condensed Consolidated Statements of Operations
| Description | Dec 31, 2020 | |
|---|---|---|
| Current | Prior Year | |
| Total Revenue | $778.80M | $828.90M |
| Cost of Revenue | $419.80M | $462.10M |
| Gross Profit | $359.00M | $366.80M |
| Operating Expenses | $241.80M | $256.80M |
| Research & Development | $72.20M | $67.10M |
| Selling General & Admin | $161.90M | $177.00M |
| Operating Income | $117.20M | $110.00M |
| Interest Expense | $1.30M | $4.70M |
| Interest Income | $2.80M | $3.00M |
| Other Income/Expense | $5.70M | $4.40M |
| Income Before Tax | $124.40M | $112.70M |
| Income Tax Expense | $27.60M | $23.80M |
| Net Income | $96.50M | $88.20M |
| Basic EPS | 1.06 | 0.97 |
| Diluted EPS | 1.05 | 0.96 |
| Basic Shares Outstanding | $91.40M | $90.90M |
| Diluted Shares Outstanding | $92.20M | $91.70M |
Condensed Consolidated Balance Sheets
| Description | Dec 31, 2020 | Sep 30, 2020 |
|---|---|---|
| Cash & Cash Equivalents | $773.30M | $766.10M |
| Accounts Receivable | $1.03B | $1.07B |
| Inventory | $571.70M | $516.30M |
| Other Current Assets | $267.00M | $254.80M |
| Total Current Assets | $2.64B | $2.60B |
| Goodwill | $627.70M | $623.90M |
| Intangible Assets | $265.00M | $271.30M |
| Other Non-current Assets | $460.70M | $416.30M |
| Total Assets | $4.53B | $4.46B |
| Accounts Payable | $206.50M | $194.90M |
| Short-term Debt | $210.00M | $355.00M |
| Accrued Liabilities | $482.70M | $522.40M |
| Deferred Revenue | $845.70M | $782.20M |
| Total Current Liabilities | $1.74B | $1.85B |
| Other Non-current Liabilities | $431.70M | $421.80M |
| Total Liabilities | $2.28B | $2.38B |
| Common Stock | $91.80M | $91.20M |
| Retained Earnings | $1.23B | $1.13B |
| Total Stockholders Equity | $2.24B | $2.08B |
| Total Liabilities & Equity | $4.53B | $4.46B |
Condensed Consolidated Statements of Cash Flows
| Description | Dec 31, 2020 | |
|---|---|---|
| Current | Prior Year | |
| Net Income | $96.50M | $88.20M |
| Stock-based Compensation | $16.70M | $14.90M |
| Deferred Income Tax | $14.90M | $1.80M |
| Change in Receivables | $-29.10M | $-29.50M |
| Change in Inventory | $52.50M | $44.90M |
| Change in Payables | $8.00M | $-32.70M |
| Operating Cash Flow | $141.40M | $112.60M |
| Capital Expenditure | $16.80M | $22.60M |
| Acquisitions | $500.00K | $1.70M |
| Purchases of Investments | $10.30M | - |
| Investing Cash Flow | $-27.60M | $-15.10M |
| Stock Repurchased | - | $43.80M |
| Financing Cash Flow | $-100.20M | $103.40M |
| Net Change in Cash | $7.30M | $198.10M |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.
Annual data represents full fiscal year results. FY = Fiscal Year ending.